ANDA 84625, held by Hikma. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 84625 (Lidocaine Hydrochloride Preservative Free), held by Hikma, was first approved by FDA on Jun 16, 1975, with 25 approved supplements and 0 published complete response letters.
Lidocaine Hydrochloride Injection is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of Lidocaine Hydrochloride Injection is recommended for each type of block indicated to produce local or regional anesthesia or analgesia.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 16, 1975 | Original application | Approved | None posted |
| Lidocaine Hydrochloride Preservative Free1% · injectable;injection | Lidocaine Hydrochloride | Rx |
| Lidocaine Hydrochloride Preservative Free2% · injectable;injection | Lidocaine Hydrochloride | Rx |
| Apr 21, 2021 | Supplement 46Labeling · Standard review | Approved | None posted |
| Jan 29, 2001 | Supplement 43Labeling | Approved | None posted |
| May 17, 1999 | Supplement 42Manufacturing | Approved | None posted |
| Mar 24, 1999 | Supplement 41Manufacturing | Approved | None posted |
| Nov 2, 1998 | Supplement 40Manufacturing | Approved | None posted |
| Feb 4, 1997 | Supplement 37Manufacturing | Approved | None posted |
| Feb 13, 1996 | Supplement 36Manufacturing | Approved | None posted |
| Feb 13, 1996 | Supplement 35Manufacturing | Approved | None posted |
| Sep 9, 1994 | Supplement 34Manufacturing | Approved | None posted |
| Feb 7, 1994 | Supplement 33Manufacturing | Approved | None posted |
| Feb 7, 1994 | Supplement 31Labeling | Approved | None posted |
| Feb 7, 1994 | Supplement 30Manufacturing | Approved | None posted |
| Jun 1, 1992 | Supplement 32Manufacturing | Approved | None posted |
| Jun 1, 1992 | Supplement 28Manufacturing | Approved | None posted |
| May 24, 1991 | Supplement 29Labeling | Approved | None posted |
| Mar 20, 1990 | Supplement 55Labeling | Approved | None posted |
| Mar 20, 1990 | Supplement 27Labeling | Approved | None posted |
| May 31, 1989 | Supplement 26Labeling | Approved | None posted |
| Apr 26, 1988 | Supplement 25Manufacturing | Approved | None posted |
| Nov 13, 1985 | Supplement 23Manufacturing | Approved | None posted |
| Apr 22, 1983 | Supplement 22Manufacturing | Approved | None posted |
| Jan 27, 1983 | Supplement 20Manufacturing | Approved | None posted |
| Nov 4, 1982 | Supplement 21Manufacturing | Approved | None posted |
| Jun 15, 1982 | Supplement 15Manufacturing | Approved | None posted |
| Mar 1, 1982 | Supplement 18Manufacturing | Approved | None posted |
| Jun 16, 1975 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters